Anxiety symptoms (state anxiety).
Conditions
Interventions
Intervention 1: Intervention group: 52 patients with mild to moderate anxiety aged between 18 and 60 years who will take 350 mg capsules of extract of flowers and aerial branches of Organum vulgare pr
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Outpatients aged 18 to 60 years, reporting anxiety Having informed consent and the ability to participate in the study Having anxiety symptoms with a minimum score of 5 on the Beck Questionnaire and a maximum score of 36 Absence of other diseases
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Any drug or food allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety severity. Timepoint: Measuring anxiety severity before the intervention and one month after the intervention. Method of measurement: Beck Anxiety Severity Scale and Cross Cutting Symptom Measure questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any possible side effects. Timepoint: At the beginning of the study (before the intervention) and after 4 weeks of taking the drug and placebo. Method of measurement: Registration by the patient and questions from the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHaleh Tajadini
Kerman University of Medical Sciences
Outcome results
None listed